AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Feb 18, 2011
30016_dirs_2011-02-18_7eeb36df-21b9-4c22-b8e2-610a8f2bdaea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-16
Reporting Person: Williams Michael J PhD (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-16 | Common Stock | S | 1260 | $78.2120 | Disposed | 9144 | Direct |
| 2011-02-16 | Common Stock | S | 79 | $78.20 | Disposed | 9065 | Direct |
| 2011-02-16 | Common Stock | M | 2472 | $25.45 | Acquired | 11537 | Direct |
| 2011-02-16 | Common Stock | M | 8128 | $25.45 | Acquired | 19665 | Direct |
| 2011-02-16 | Common Stock | S | 10600 | $78.1270 | Disposed | 9065 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-16 | Incentive Stock Option (right to buy) | $25.45 | M | 8128 | Disposed | 2014-02-04 | Common Stock (8128) | Direct |
| 2011-02-16 | Non-Qualified Stock Option (right to buy) | $25.45 | M | 2472 | Disposed | 2014-02-04 | Common Stock (2472) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $78.1736 to $78.2800, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $78.0700 to $78.2500, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 1,352 shares on 02/05/2005, 02/05/2006, 02/05/2007, 02/05/2008, and the remaining 2,720 shares on 02/05/2009.
F4: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/05/2005) of the date of grant.